Wang et al. demonstrated that the NLR and serum albumin could be combined to provide additional risk stratification for ovarian cancer,21 it has also been reported that the combination of serum albumin and NLR was significantly associated with OS and disease‐free survival (DFS) of GC patients submitted to curative surgery.22, 23. The gene discussed is ALB; the disease is ovarian cancer.